Table 1.
Main endotoxin tolerance features found in different tissues according to the models used
Tissue/cell type | Model | Stimuli a | Most relevant phenotype | Reference |
---|---|---|---|---|
bPeritoneal macrophage |
In vitro |
LPS + LPS |
TNF-α, IL-1β, GMCSF, CCL2, CCL4, CXCL10, CXCL2 |
[35] |
bPeritoneal macrophage |
In vitro |
LPS + LPS |
↓ TNF-α, IL-1β, IL-12p40, COX2, CXCL10, ↓ TNF-α, IL-1β, IL-12p40, COX2, CXCL10 = TNF-α, IL-1β, ↓ IL-12p40, COX2, CXCL10, ↓ TNF-α, IL-1β, IL-12p40, COX2, ↑CXCL10 = TNF-α, ↓ CXCL10, ↓ TNF-α, ↑ CXCL10 |
[36] |
MALP2 + MALP2 | ||||
LPS + MALP2 | ||||
MALP2 + LPS | ||||
Poli(I:C) + LPS | ||||
R848 + LPS | ||||
bPeritoneal macrophage |
In vitro |
LPS + LPS |
↓ TNF-α, IFN-β |
[37] |
Pam3Cys + Pam3Cys |
↓ TNF-α , = TNF-α |
|||
LPS + Pam3Cys |
↑ TNF-α, = IFN-β |
|||
Pam3Cys + LPS | ||||
bBMMs |
In vitro |
LPS + LPS |
↓ inflammatory genes (IL-6, IL-1β, MMP3) |
[28]c |
↑ antimicrobial genes (Fpr1, Oasl1) | ||||
bBMMs |
In vitro |
LipidA + LipidA |
↓ TNF-α, CCL3, ↑ IFN-β, IL-10 |
[38] |
Pam3Cys + Pam3Cys |
↓ TNF-α, CCL3 |
|||
LipidA + Pam3Cys |
= TNF-α, CCL3, IFN-β |
|||
= TNF-α, CCL3, IFN-β | ||||
Pam3Cys + LipidA |
↓ TNF-α, CCL3, ↑ IFN-β, IL-10 |
|||
Poli(I:C) + LipidA | ||||
dMonocytes |
In vitro |
LPS + LPS |
↓ inflammatory cytokines/chemokines |
[17]c |
↑ IFN-β, TGF-β | ||||
↑ Scavenger receptors | ||||
↑ Phagocytic capacity | ||||
↓ Antigen presentation potential | ||||
dPBMCs |
In vitro |
LPS + LPS |
↓ TNF-α, IL−12, ↑ IL-10, COX2 |
[19] |
ePBMCs |
In vitro |
LPS + LPS |
↓ TNF-α, IL-12, ↑ IL-10 |
[39] |
dSeptic monocytes |
Ex vivo |
Monocytes from patients with sepsis + LPS |
↓ TNF-α, IL6, IL-1β |
[6] |
dWhole blood |
Ex vivo |
LPS injection + ex vivo restimulation |
↓ TNF-α, IL6, IL-10 |
[11] |
bPeritoneal/splenic macrophage |
Ex vivo |
LPS injection + ex vivo restimulation |
↓ TNF-α, IL6, CXCL8 = IL-10, IL-1RA |
[40] |
fMammary tissue |
In vivo |
LPS + E. coli injection |
↓ TNF-α, IL6, CXCL8, CCL20, ↑ IL-10 |
[41] |
dSerum |
In vivo |
5 consecutive LPS injections |
↓ elastase, TNF-α, IL-6, IL-10, IL-1RA = TGF-β |
[42] |
dPlasma | In vivo | 2 consecutive LPS inoculations | ↓ TNF-α, IL6, IL-10, IL-1RA, TGF-β | [11] |
aLipopolysaccharide (LPS) – TLR4 ligand; MALP2 – TLR2 ligand; Poli(I:C) – TLR3 ligand; R848 – TLR7/8 ligand; LipidA – TLR4 ligand; bmurine; cgenome-wide analysis; dhuman; eequine; fbovine. BMM, bone marrow-derived macrophage; IL, interleukin; MALP2, macrophage-activating lipopeptide-2; PBMC, peripheral blood mononuclear cell; TGF-β, transforming growth factor-beta; TLR, Toll-like receptor; TNF, tumor necrosis factor.